1. Home
  2. MBOT vs INCR Comparison

MBOT vs INCR Comparison

Compare MBOT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$0.68

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

SELL

Current Price

$3.50

Market Cap

58.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MBOT
INCR
Founded
2010
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.2M
58.6M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
MBOT
INCR
Price
$0.68
$3.50
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
★ 1.3M
9.8K
Earning Date
11-16-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 60.27
N/A
EPS
N/A
★ N/A
Revenue
★ $116,887.00
N/A
Revenue This Year
N/A
$222.95
Revenue Next Year
$328.60
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.68
52 Week High
$2.86
$6.10

Technical Indicators

Market Signals
Indicator
MBOT
INCR
Relative Strength Index (RSI) 30.65 32.01
Support Level N/A $3.12
Resistance Level $1.18 $4.19
Average True Range (ATR) 0.08 0.25
MACD -0.03 -0.01
Stochastic Oscillator 24.43 15.00

Price Performance

Historical Comparison
MBOT
INCR

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: